Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
AcuCort
Market Cap: SEK 170.7m
Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.
ACUC
SEK 0.76
7D
2.0%
1Y
-9.9%
Sweet Earth Holdings
Market Cap: CA$6.6m
Does not have significant operations.
SE
CA$0.51
7D
0%
1Y
410.0%
Entheon Biomedical
Market Cap: CA$1.2m
Operates as a biotechnology research and development company.
ENBI
CA$0.085
7D
-15.0%
1Y
-15.0%
Tchaikapharma High Quality Medicines AD
Market Cap: лв1.7b
Develops, manufactures, and sells medicines in Bulgaria.
THQM
лв17.70
7D
4.1%
1Y
6.3%
Shine-On BioMedicalLtd
Market Cap: NT$3.7b
Research, develops, and manufactures anti-cancer related drug products.
6926
NT$75.20
7D
2.2%
1Y
17.9%
Aether Industries
Market Cap: ₹98.1b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹740.60
7D
1.2%
1Y
-19.4%
Hualan Biological Vaccine
Market Cap: CN¥10.3b
Engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China.
301207
CN¥17.26
7D
-1.8%
1Y
2.1%
CHO Pharma
Market Cap: NT$8.2b
Engages in research and development of biotechnology in Taiwan.
6586
NT$38.25
7D
-0.6%
1Y
-33.0%
Shaperon
Market Cap: ₩89.1b
A clinical stage biotech company, develops novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and nanobody therapeutics.
A378800
₩2,955.00
7D
38.7%
1Y
-32.8%
Beit Jala Pharmaceutical
Market Cap: د.أ19.6m
Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
BJP
د.أ2.80
7D
0%
1Y
n/a
BIONET Therapeutics
Market Cap: NT$4.0b
A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.
7808
NT$57.00
7D
5.6%
1Y
n/a
Intelligene
Market Cap: NT$5.6b
Engages in the development of RNA gene therapy drugs for infectious diseases.
7832
NT$9.67
7D
-2.2%
1Y
n/a
Sunhawk Vision Biotech
Market Cap: NT$5.2b
Operates as a drug development company that develops microRNA therapeutic eye drops.
7759
NT$73.70
7D
-6.4%
1Y
n/a
Novogene
Market Cap: CN¥6.3b
Provides genomic services and solutions in Mainland China, Hong Kong, Macau, Taiwan, and internationally.
688315
CN¥15.54
7D
-1.9%
1Y
48.4%
PharmaEngine
Market Cap: NT$9.7b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$67.40
7D
2.4%
1Y
-22.2%
Rhone Ma Holdings Berhad
Market Cap: RM 143.2m
An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.
RHONEMA
RM 0.65
7D
-2.3%
1Y
-11.0%
HeXun Biosciences
Market Cap: NT$2.9b
Engages in the research and development of stem cell and treatments in Taiwan.
6986
NT$63.20
7D
-1.7%
1Y
-16.7%
Otsuka Holdings
Market Cap: JP¥4.2t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥8,000.00
7D
-2.2%
1Y
-3.0%
Suzhou Sepax Technologies
Market Cap: CN¥7.6b
Researches, develops, produces, and sells liquid chromatography materials for the separation and purification of biomacromolecules and other drugs worldwide.
688758
CN¥18.30
7D
0.4%
1Y
n/a
Suzhou Highfine Biotech
Market Cap: CN¥5.7b
Manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China.
301393
CN¥53.12
7D
-6.3%
1Y
41.5%
HBM Holdings
Market Cap: HK$11.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$14.06
7D
-9.1%
1Y
1,052.5%
Genor Biopharma Holdings
Market Cap: HK$2.1b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$3.94
7D
-5.5%
1Y
n/a
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.4b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.90
7D
0.6%
1Y
39.4%
Hangzhou Biotest BiotechLtd
Market Cap: CN¥6.1b
Engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally.
688767
CN¥41.50
7D
-2.8%
1Y
122.8%
BIO-FD&CLtd
Market Cap: ₩155.0b
Develops active ingredients for anti-aging cosmetics in South Korea.
A251120
₩17,820.00
7D
-2.6%
1Y
22.9%
MFC
Market Cap: ₩35.7b
Operates as a pharmaceutical company in South Korea.
A432980
₩4,155.00
7D
1.2%
1Y
n/a
Synmosa Biopharma
Market Cap: NT$15.8b
A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.
4114
NT$34.60
7D
-1.7%
1Y
1.9%
Clinuvel Pharmaceuticals
Market Cap: AU$561.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.20
7D
-2.8%
1Y
-21.7%
Aurobindo Pharma
Market Cap: ₹638.0b
A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.
AUROPHARMA
₹1,097.00
7D
-2.8%
1Y
-27.6%
TCM Biotech International
Market Cap: NT$6.9b
A biotech company, engages in the research and development of drugs for liver diseases.
4169
NT$116.50
7D
-1.3%
1Y
90.4%
JSP Pharmaceutical Manufacturing (Thailand) Public
Market Cap: ฿915.9m
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
JSP
฿1.93
7D
5.5%
1Y
-11.5%
Asymchem Laboratories (Tianjin)
Market Cap: CN¥39.6b
Asymchem Laboratories (Tianjin) Co., Ltd.
002821
CN¥111.72
7D
-2.2%
1Y
61.0%
Shanghai Haixin Group
Market Cap: CN¥5.8b
Engages in the pharmaceutical, textile and clothing, and finance businesses.
600851
CN¥6.56
7D
-3.1%
1Y
23.5%
Sanjivani Paranteral
Market Cap: ₹2.9b
Operates as a pharmaceutical company in India.
531569
₹239.90
7D
0.2%
1Y
-16.3%
Carna Biosciences
Market Cap: JP¥4.3b
A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.
4572
JP¥225.00
7D
1.8%
1Y
-42.0%